Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by J Blazquez
Characterization of a New TEM-type Beta-Lactamase Resistant to Clavulanate, Sulbactam, and Tazobactam in a Clinical Isolate of Escherichia Coli.
Antimicrobial Agents and Chemotherapy
Infectious Diseases
Pharmacology
Related publications
CTX-M-190, a Novel Β-Lactamase Resistant to Tazobactam and Sulbactam, Identified in an Escherichia Coli Clinical Isolate
Antimicrobial Agents and Chemotherapy
Infectious Diseases
Pharmacology
TEM-80, a Novel Inhibitor-Resistant -Lactamase in a Clinical Isolate of Enterobacter Cloacae
Antimicrobial Agents and Chemotherapy
Infectious Diseases
Pharmacology
A Complex Mutant of TEM-1 Beta-Lactamase With Mutations Encountered in Both IRT-4 and Extended-Spectrum TEM-15, Produced by an Escherichia Coli Clinical Isolate.
Antimicrobial Agents and Chemotherapy
Infectious Diseases
Pharmacology
Molecular Detection of TEM Broad Spectrum -Lactamase in Clinical Isolates of Escherichia Coli
African Journal of Biotechnology
Norfloxacin Resistance in a Clinical Isolate of Escherichia Coli.
Antimicrobial Agents and Chemotherapy
Infectious Diseases
Pharmacology
Phenotypic and Molecular Characterization of Extended-Spectrum Beta-Lactamase-Producing Escherichia Coli in Bangladesh
PLoS ONE
Multidisciplinary
Prevalence and Characterization of Extended Spectrum Beta Lactamase Producing Escherichia Coli From Broilers
International Journal of Current Microbiology and Applied Sciences
A Novel Complex Mutant Beta -Lactamase, TEM-68, Identified in a Klebsiella Pneumoniae Isolate From an Outbreak of Extended-Spectrum Beta -Lactamase-Producing Klebsiellae
Antimicrobial Agents and Chemotherapy
Infectious Diseases
Pharmacology
Mechanisms of Quinolone Resistance in a Clinical Isolate of Escherichia Coli Highly Resistant to Fluoroquinolones but Susceptible to Nalidixic Acid.
Antimicrobial Agents and Chemotherapy
Infectious Diseases
Pharmacology